Characterization of wheezing phenotypes in the first 10 years of life

R J Kurukulaaratchy1, M H Fenn, L M Waterhouse

  • 1The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Newport, Isle of Wight, UK. sha@soto.ac.uk

Insights

Persistent childhood wheezing starting early is linked to significant health issues, including asthma and reduced lung function. Late-onset wheezing may also lead to future health problems.

Area of Science:

  • Pediatric Respiratory Medicine
  • Phenotyping Childhood Illnesses
  • Longitudinal Cohort Studies

Background:

  • Childhood wheezing illnesses present diverse phenotypes, but their associated disease severity requires further investigation.
  • Understanding wheezing phenotypes is crucial for predicting long-term health outcomes in children.

Purpose of the Study:

  • To characterize childhood wheezing phenotypes within the first decade of life.
  • To assess health outcomes, atopy, lung function, and bronchial hyper-responsiveness in relation to wheezing phenotypes.

Main Methods:

  • Prospective study of a whole population birth cohort (n=1456) tracking wheezing natural history.
  • Phenotyping wheezing based on symptom onset and persistence up to 10 years of age.
  • Assessed adverse health outcomes, spirometry, bronchial hyper-responsiveness, IgE, and skin sensitization at ages 1, 2, 4, and 10 years.

Main Results:

  • 37% of early-onset wheezers continued to wheeze at 10 years, showing higher rates of asthma, hospital admissions, and steroid use.
  • Persistent wheezers exhibited significantly increased bronchial hyper-responsiveness compared to transient wheezers.
  • Both early wheezing groups showed impaired lung function (FEV1, FEV1/FVC ratio, PEF) at age 10 compared to non-wheezers.
  • Late-onset wheezers had normal lung function and fewer adverse outcomes than persistent wheezers but similar bronchial hyper-responsiveness.

Conclusions:

  • Early-onset persistent wheezing in children is associated with significant morbidity, including atopy, bronchial hyper-responsiveness, and impaired lung function.
  • Late-onset wheezing in early childhood may indicate potential for significant future respiratory disease.
Abstract

Related Concept Videos

Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.